Dexrazoxane HCl (ICRF-187, ADR-529)

Modify Date: 2024-01-05 20:56:11

Dexrazoxane HCl (ICRF-187, ADR-529) Structure
Dexrazoxane HCl (ICRF-187, ADR-529) structure
Common Name Dexrazoxane HCl (ICRF-187, ADR-529)
CAS Number 149003-01-0 Molecular Weight 304.73000
Density N/A Boiling Point 531.5ºC at 760 mmHg
Molecular Formula C11H17ClN4O4 Melting Point 193ºC
MSDS N/A Flash Point 275.3ºC

 Use of Dexrazoxane HCl (ICRF-187, ADR-529)


Dexrazoxane Hcl( ICRF-187 Hcl) is a cardioprotective agent. IC50 value:Target: cardioprotective agentAs a derivative of EDTA, dexrazoxane chelates iron, thus reduce the number of metal ions complexed with anthracycline and, consequently, decrease the formation of superoxide radicals. This agent is used to protect the heart against the cardiotoxic side effects of anthracyclines, such as doxorubicin. It was speculated that dexrazoxane could be used for further investigation to synthesize new antimalarial drugs.

 Names

Name dexrazoxane hydrochloride
Synonym More Synonyms

 Dexrazoxane HCl (ICRF-187, ADR-529) Biological Activity

Description Dexrazoxane Hcl( ICRF-187 Hcl) is a cardioprotective agent. IC50 value:Target: cardioprotective agentAs a derivative of EDTA, dexrazoxane chelates iron, thus reduce the number of metal ions complexed with anthracycline and, consequently, decrease the formation of superoxide radicals. This agent is used to protect the heart against the cardiotoxic side effects of anthracyclines, such as doxorubicin. It was speculated that dexrazoxane could be used for further investigation to synthesize new antimalarial drugs.
Related Catalog
References

[1]. Hasinoff BB. The use of dexrazoxane for the prevention of anthracycline extravasation injury. Expert Opin Investig Drugs. 2008 Feb;17(2):217-23.

[2]. Jones RL. Utility of dexrazoxane for the reduction of anthracycline-induced cardiotoxicity. Expert Rev Cardiovasc Ther. 2008 Nov;6(10):1311-7.

[3]. Lipshultz SE, Scully RE, Lipsitz SR et al. Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial. Lancet Oncol. 201

 Chemical & Physical Properties

Boiling Point 531.5ºC at 760 mmHg
Melting Point 193ºC
Molecular Formula C11H17ClN4O4
Molecular Weight 304.73000
Flash Point 275.3ºC
Exact Mass 304.09400
PSA 98.82000
Vapour Pressure 2.22E-11mmHg at 25°C
Storage condition -20°C

 Safety Information

Hazard Codes Xi

 Synonyms

2,6-Piperazinedione, 4-[(1S)-2-(3,5-dioxo-1-piperazinyl)-1-methylethyl]-, hydrochloride (1:1)
4,4'-(2S)-Propan-1,2-diyldipiperazin-2,6-dionhydrochlorid
4,4'-(2S)-propane-1,2-diyldipipérazine-2,6-dione chlorhydrate
(S)-4,4'-(1-Methyl-1,2-ethanediyl)bis-2,6-piperazinedionehydrochloride
Dexrazoxane hydrochloride
2,6-Piperazinedione, 4,4'-[(1S)-1-methyl-1,2-ethanediyl]bis-, hydrochloride (1:1)
4,4'-[(2S)-1,2-Propanediyl]di(2,6-piperazinedione) hydrochloride (1:1)
2,6-piperazinedione, 4,4'-[(1S)-1-methyl-1,2-ethanediyl]bis-, monohydrochloride
4,4'-(2S)-Propane-1,2-diyldipiperazine-2,6-dione hydrochloride (1:1)
Dexrazoxane HCl
UNII:5346058Q7S
Dexrazoxane (Hydrochloride)